The Inactivated Vaccines Market was valued at US$ 40.6 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 ...

The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the ...

Zydus Lifesciences introduces India's first quadrivalent influenza vaccine, VaxiFlu-4, for protection against four new virus strains as per WHO recommendations. The vaccine, developed at Zydus's ...

Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...

An in-house reverse-genetics generated H5N9 inactivated vaccine (SEP-22- N9) was evaluated for its vaccine efficacy in ...

CLEVELAND, Ohio — Eggs are disappearing from store shelves due to shortages caused by the avian flu outbreak, but never fear ...

In the type segment of the influenza vaccine market, the inactivated influenza vaccine category generated a significant revenue share in the influenza vaccine market in 2024. Notable influenza ...

Commercially available vaccines include egg- or cell-based inactivated, live attenuated and recombinant influenza vaccines. To develop more effective vaccines, a deeper understanding of influenza ...

VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives. The Quadrivalent Inactivated ...

In part A, patients were randomly assigned 7:10:10 to receive either RSV mRNA-1345 vaccine plus placebo, mRNA-1345 plus standard-dose quadrivalent inactivated influenza vaccine (SIIV4), or SIIV4 ...